A股異動丨高偉達(300465.SZ)大跌9% 2020年全年預虧+收關注函
格隆匯1月19日丨高偉達(300465.SZ)盤初一度暴跌超16%,現回升至8.89%,報10.13元創逾1年新低價,大幅成交2.46億元,總市值45.26億元。高偉達18日公吿,公司擬計提商譽減值準備6.45億-7.94億元,預計2020年全年虧損5.32億-6.88億元,同比由盈轉虧。隨即深交所對高偉達下發關注函,要求補充説明商譽減值準備計提及相關風險提示是否及時、充分,是否存在通過集中計提大額商譽減值準備調節利潤的情形。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.